Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

mHealth-fyysisen aktiivisuuden interventio nuorille syövästä selviytyneille (AYA-PACT)

tiistai 17. marraskuuta 2026 päivittänyt: AHS Cancer Control Alberta

Nuoret ja nuoret aikuiset, jotka tulevat fyysisesti aktiivisiksi syöpäkokeen jälkeen

In this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a first cancer between the ages of 15 to 39 years and are within one year of treatment completion. Participants will be randomized into either the control group (educational information) or the intervention group (educational information; personalized physical activity plan; activity tracker watch; access to a private, online survivor community; motivational text messages and check-in calls/e-mails). All participants will complete fitness testing and questionnaires at baseline, 6 months and 12 months. A final measurement at 24 months will test long-term effectiveness.

Tutkimuksen yleiskatsaus

Tila

Aktiivinen, ei rekrytointi

Ehdot

Yksityiskohtainen kuvaus

Background:

There is a need for adolescent and young adult (AYA) cancer research because the number of new cancers in young people is increasing and the survivor population is growing. Interventions that try to reduce problems that affect people after cancer are particularly important since its treatments can have negative effects on survivors' physical and mental health even decades after diagnosis.

Aim:

Given the many positive effects of physical activity (e.g. improved fitness and quality of life), the study aims to encourage AYA cancer survivors to be more physically active as they shift from treatment to survivorship care. The main goal of this study is to see if a home-based, mobile health (mHealth) physical activity intervention can increase physical activity levels by at least 90 minutes/week compared to baseline in AYA cancer survivors.

Methods:

The investigators will conduct a two-center randomized controlled trial of 320 AYA cancer survivors. Participants (N=320) will be Albertan residents, diagnosed with a first cancer between the ages of 15 and 39 years, and within one year of cancer treatment completion. At the start of the study, participants will complete fitness testing and questionnaires. Participants will then be randomly put into either a control or intervention group. The control group will receive educational information only. The intervention group will also receive a personalized physical activity plan, an activity tracker watch, access to a private, online survivor community, motivational text messages and check-in calls/e-mails. Fitness testing and questionnaires will be repeated at 6 and 12 months to see if the intervention increased physical activity levels and improved health outcomes among the participants in the intervention group compared to controls. A final measurement at 24 months will test long-term use.

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

287

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Alberta
      • Calgary, Alberta, Kanada, T2N5G2
        • Arthur J.E. Child Comprehensive Cancer Centre
      • Edmonton, Alberta, Kanada, T6G2H9
        • University of Alberta

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

15 vuotta - 39 vuotta (Lapsi, Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Lives in Alberta
  • Diagnosed with invasive malignancy in Alberta
  • Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) in the last 12 months, except for "maintenance" therapy to prevent recurrences
  • Have the ability to read, write and speak English
  • Have access to the Internet on at least a weekly basis
  • Have a mobile phone with a text messaging plan
  • Willing to be randomized to either arm.

Exclusion Criteria:

  • Health problems which preclude the ability to walk for physical activity, as measured by the Physical Activity Readiness Questionnaire (PAR-Q)
  • Currently pregnant or planning to become pregnant within the next 6 months
  • Currently taking part in > 300 minutes/week of moderate-to-vigorous intensity physical activity on a regular basis

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Tukevaa hoitoa
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Kaksinkertainen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: mHealth Physical Activity Intervention

The intervention arm will receive a 12 month mobile health (mHealth) physical activity intervention with a goal of increasing their moderate-vigorous intensity physical activity levels by 90 minutes per week above baseline.

The intervention includes a physical activity prescription, a Polar activity tracker watch, access to a private AYA cancer survivor community through the Polar Flow community platform, mHealth nudges and surveys via text messaging, and regular phone or email contact from study staff.

Ei väliintuloa: Control

Controls received "standard of care" from their medical team and were not provided with any physical activity guidance.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Changes in weekly minutes of moderate-vigorous intensity physical activity
Aikaikkuna: Baseline to 12 months

Measured by ActiGraph

Baseline to 12 months

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Changes in weekly minutes of moderate-vigorous intensity physical activity
Aikaikkuna: Baseline to 6 months and 24 months.

Measured by ActiGraph

Baseline to 6 months and 24 months.
Changes in weekly minutes of sleep
Aikaikkuna: Baseline, 6 months, 12 months, 24 months

Measured by ActiGraph

Baseline, 6 months, 12 months, 24 months
Changes in weekly minutes of sedentary time
Aikaikkuna: Baseline, 6 months,12 months, 24 months

Measured by ActiGraph

Baseline, 6 months,12 months, 24 months
Changes in moderate-vigorous physical activity using the self-administered Past Year Total Physical Activity Questionnaire (PYTPAQ).
Aikaikkuna: Baseline, 12 months, 24 months.

Met-Hours per week and hours per week of moderate-vigorous physical activity

Baseline, 12 months, 24 months.
Changes in the Pittsburgh Sleep Quality Index (PSQI) Global Sleep Quality Score
Aikaikkuna: Baseline, 6 months,12 months

Global score range is 0 to 23 where higher scores indicate worse sleep quality

Baseline, 6 months,12 months
Changes in weight
Aikaikkuna: Baseline, 6 months,12 months

Measured in kilograms

Baseline, 6 months,12 months
Changes in body mass index (BMI)
Aikaikkuna: Baseline, 6 months,12 months

Measured by combining height (meters) and weight (kilograms) and reported in kg/m2

Baseline, 6 months,12 months
Changes in waist and hip circumference
Aikaikkuna: Baseline, 6 months,12 months

Measured in centimeters

Baseline, 6 months,12 months
Changes in cardiorespiratory fitness
Aikaikkuna: Baseline, 6 months,12 months

Measured by peak oxygen consumption in relative (ml/kg/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation

Baseline, 6 months,12 months
Changes in cardiorespiratory fitness
Aikaikkuna: Baseline, 6 months,12 months

Measured by peak oxygen consumption in absolute (L/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation

Baseline, 6 months,12 months
Changes in grip strength
Aikaikkuna: Baseline, 6 months,12 months

Measured in kilograms using a hand dynamometer

Baseline, 6 months,12 months
Changes in upper body muscular strength
Aikaikkuna: Baseline, 6 months,12 months

Measured in kilograms using an 8-10 repetition maximum (RM) chest press test used to predict 1-RM

Baseline, 6 months,12 months
Changes in upper body muscular endurance
Aikaikkuna: Baseline, 6 months,12 months

Measured in kilograms using the maximum number of chest press repetitions completed at 50% of estimated 1-RM

Baseline, 6 months,12 months
Changes in lower body muscular strength
Aikaikkuna: Baseline, 6 months,12 months

Measured in kilograms using an 8-10 repetition maximum (RM) leg press test used to predict 1-RM

Baseline, 6 months,12 months
Changes in lower body muscular endurance
Aikaikkuna: Baseline, 6 months,12 months

Measured in kilograms using the maximum number of leg press repetitions completed at 70% of estimated 1-RM

Baseline, 6 months,12 months
Changes in frailty
Aikaikkuna: Baseline, 6 months,12 months

Defined according to the Fried phenotype which takes into account low lean muscle mass, exhaustion, low energy expenditure, walking limitations, and weakness

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Mental Health Component subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better mental health

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Physical Health Component subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better physical health

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Physical Functioning subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Role-physical subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Bodily Pain subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate less pain

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) General Health subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better health

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Vitality subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher vitality

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Social Functioning subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Role-emotional subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 Mental Health subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better mental health

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Impact of Cancer subscale
Aikaikkuna: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Physical subscale
Aikaikkuna: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Emotional subscale
Aikaikkuna: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Cognitive subscale
Aikaikkuna: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Cancer Worry subscale
Aikaikkuna: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function Perceived Cognitive Impairment subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 72. Higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Comments From Others subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 16 where higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Perceived Cognitive Abilities subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 36 where higher scores indicate poorer cognition

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Impact on Quality of Life subscale
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 16 where higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Fatigue (FACT-F)
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 52 where higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Comprehensive Score for Financial Toxicity (COST)
Aikaikkuna: Baseline, 6 months,12 months

Score range is from 0 to 44 where higher scores indicate better financial wellbeing

Baseline, 6 months,12 months
Changes in fear of cancer recurrence - short form (FCRI-SF)
Aikaikkuna: Baseline, 6 months, 12 months

Score range is from 0 - 36 where higher scores indicate greater fear of recurrence severity.

Baseline, 6 months, 12 months
Changes in Sedentary Behaviour using a 7 day Sedentary Recall
Aikaikkuna: Baseline, 6 months, 12 months.

Hours of sitting during the week and on weekends for the following categories: (1) traveling to work, (2) at work or school, (3) watching television, (4) using a computer, and (5) leisure time not including television.

Baseline, 6 months, 12 months.
Changes in environmental barriers that prevent or limit walking and cycling where a person lives or works - PANES Questionnaire
Aikaikkuna: Baseline, 6 months, 12 months.

Score range is from 1 to 4 with higher values indicating greater environmental support for physical activity.

Baseline, 6 months, 12 months.
Changes in Exercise Self-Efficacy - Subscale (FITNET Questionnaire)
Aikaikkuna: Baseline, 6 months, 12 months

Range of scores from 11 to 55 with higher scores indicated higher self-efficacy.

Baseline, 6 months, 12 months
Changes in Social Support from Family and Friends related to Exercise - Subscale (FITNET Questionnaire)
Aikaikkuna: Baseline, 6 months, 12 months.

Range of scores from 10 to 50 with higher scores indicating more support.

Baseline, 6 months, 12 months.
Changes in Self-Monitoring related to setting exercise goals and planning exercise activities - Subscale (FITNET Questionnaire)
Aikaikkuna: Baseline, 6 months, 12 months.

Range of scores from 12 to 60 with higher scores indicating more self-monitoring.

Baseline, 6 months, 12 months.

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Yhteistyökumppanit

Tutkijat

  • Opintojohtaja: Miranda Fidler-Benaoudia, PhD, Cancer Care Alberta
  • Päätutkija: Christine Friedenreich, PhD, Cancer Care Alberta

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Maanantai 27. syyskuuta 2021

Ensisijainen valmistuminen (Todellinen)

Torstai 16. heinäkuuta 2026

Opintojen valmistuminen (Arvioitu)

Lauantai 1. toukokuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Tiistai 9. helmikuuta 2021

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Perjantai 19. helmikuuta 2021

Ensimmäinen Lähetetty (Todellinen)

Sunnuntai 21. helmikuuta 2021

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Perjantai 20. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Tiistai 17. marraskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa